FDA grants tentative approval for Viatris’ pediatric HIV drug

FDA grants tentative approval for Viatris’ pediatric HIV drug

Source: 
Business Today
snippet: 
  • Viatris Inc. gains FDA tentative approval for abacavir/dolutegravir/lamivudine to treat paediatric HIV-1 patients.
  • WHO endorses the medication as a preferred treatment for paediatric HIV, highlighting a significant treatment gap for children with HIV